Search by Drug Name or NDC

    NDC 44523-0741-01 Hyophen 9; .12; 81.6; 10.8; 36.2 mg/1; mg/1; mg/1; mg/1; mg/1 Details

    Hyophen 9; .12; 81.6; 10.8; 36.2 mg/1; mg/1; mg/1; mg/1; mg/1

    Hyophen is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by BioComp Pharma, Inc.. The primary component is BENZOIC ACID; HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE.

    Product Information

    NDC 44523-0741
    Product ID 44523-741_ed117f88-49b2-dd3d-e053-2a95a90ac03d
    Associated GPIs 16992005150325
    GCN Sequence Number 060244
    GCN Sequence Number Description methenam/m.blue/salicyl/hyoscy TABLET 81.6-0.12 ORAL
    HIC3 W2G
    HIC3 Description ANTIBIOTIC, ANTIBACTERIAL, MISC.
    GCN 26339
    HICL Sequence Number 033419
    HICL Sequence Number Description METHENAMINE/METHYLENE BLUE/BENZOIC ACID/SALICYLAT/HYOSCYAMIN
    Brand/Generic Generic
    Proprietary Name Hyophen
    Proprietary Name Suffix n/a
    Non-Proprietary Name Methenamine, Benzoic Acid, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 9; .12; 81.6; 10.8; 36.2
    Active Ingredient Units mg/1; mg/1; mg/1; mg/1; mg/1
    Substance Name BENZOIC ACID; HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE
    Labeler Name BioComp Pharma, Inc.
    Pharmaceutical Class Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2023-12-31

    Package

    NDC 44523-0741-01 (44523074101)

    NDC Package Code 44523-741-01
    Billing NDC 44523074101
    Package 100 TABLET in 1 BOTTLE (44523-741-01)
    Marketing Start Date 2010-09-21
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 913261ab-65e9-e45a-e053-2995a90ad08f Details

    Revised: 11/2022